Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma
Open Access
- 12 December 2024
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-20
Abstract
Anti-disialoganglioside (GD2) antibody therapy has provided clinical benefit to patients with neuroblastoma however efficacy is likely impaired by the immunosuppressive tumor microenvironment. We have previously defined a link between intratumoral copper levels and immune evasion. Here, we report that adjuvant copper chelation potentiates anti-GD2 antibody therapy to confer durable tumor control in immunocompetent models of neuroblastoma. Mechanistic studies reveal copper chelation creates an immune-primed tumor microenvironment through enhanced infiltration and activity of Fc-receptor-bearing cells, specifically neutrophils which are emerging as key effectors of antibody therapy. Moreover, we report copper sequestration by neuroblastoma attenuates neutrophil function which can be successfully reversed using copper chelation to increase pro-inflammatory effector functions. Importantly, we repurpose the clinically approved copper chelating agent Cuprior as a non-toxic, efficacious immunomodulatory strategy. Collectively, our findings provide evidence for the clinical testing of Cuprior as an adjuvant to enhance the activity of anti-GD2 antibody therapy and improve outcomes for patients with neuroblastoma.Keywords
Funding Information
- Cure Cancer Australia Foundation (CCAF2023)
- Department of Health | National Health and Medical Research Council (GNT2012567)
- icare (ICARE2023)
- Cancer Council Western Australia (CCWA1343)
This publication has 85 references indexed in Scilit:
- High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancerCancer Cell, 2022
- During early stages of cancer, neutrophils initiate anti-tumor immune responses in tumor-draining lymph nodesCell Reports, 2022
- Copper: An Intracellular Achilles’ Heel Allowing the Targeting of Epigenetics, Kinase Pathways, and Cell Metabolism in Cancer TherapeuticsChemMedChem, 2021
- Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19Cell Host & Microbe, 2021
- Copper metabolism as a unique vulnerability in cancerBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2020
- Transcriptome analysis of copper homeostasis genes reveals coordinated upregulation of SLC31A1,SCO1, and COX11 in colorectal cancerFEBS Open Bio, 2016
- Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in CancerCell Reports, 2015
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TANCancer Cell, 2009
- Gene expression profiling of liver cells after copper overload in vivo and in vitro reveals new copper-regulated genesJBIC Journal of Biological Inorganic Chemistry, 2007
- Activation of bovine neutrophils by recombinant interferon-γCellular Immunology, 1986